TrialMolecular biology reports2020

The impact of CYP2D6*4 and GSTP1 Ile105Val polymorphisms on the susceptibility to develop BCR-ABL1 negative myeloproliferative neoplasms.

Aynur Daglar-Aday et al.PubMed ↗Publisher ↗

No numbers read from the abstract.